Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.2 First Amendment to Amended and Restated Memorandum and Articles of Association of Health Sciences
- 4.2 Warrant to Purchase Ordinary Shares of Health Sciences Acquisitions Corporation 2 Issued to Hsac 2 Holdings, LLC, Dated August 6, 2020
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Withumsmith+brown, PC, Independent Registered Public Accounting Firm of Health Sciences Acquisitions Corporation 2
- 23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Orchestra Biomed, Inc.
- 99.1 Consent of Eric A. Rose, M.D. to Be Named As a Director Nominee
- 99.2 Consent of Jason Aryeh to Be Named As a Director Nominee
- 99.3 Consent of Pamela Y. Connealy to Be Named As a Director Nominee
- 99.4 Consent of Geoffrey W. Smith to Be Named As a Director Nominee
- 99.5 Consent of David P. Hochman to Be Named As a Director Nominee
- 99.6 Consent of Darren R. Sherman to Be Named As a Director Nominee
- 99.7 Consent of Eric S. Fain, M.D. to Be Named As a Director Nominee
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
- 19 Dec 22 EFFECT Notice of effectiveness
- 16 Dec 22 424B3 Prospectus supplement
- 12 Dec 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
8 Aug 22 S-4 Registration of securities issued in business combination transactions
OBIO similar filings
- 21 Nov 22 Registration of securities issued in business combination transactions (amended)
- 21 Oct 22 Registration of securities issued in business combination transactions (amended)
- 23 Sep 22 Registration of securities issued in business combination transactions (amended)
- 8 Aug 22 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 8, 2022, with respect to the consolidated financial statements of Orchestra BioMed, Inc. included in the Registration Statement on Form S-4 and related Prospectus of Health Sciences Acquisitions Corporation 2 for the registration of 31,637,180 shares of its common stock and 2,321,288 warrants.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
August 8, 2022